SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that John Higgins, President and Chief Executive Officer of Ligand, will present at the Oppenheimer 22nd Annual Healthcare Conference on Wednesday, December 14, 2011 at 1:00 p.m. Eastern time (10:00 a.m. Pacific). The conference takes place at the Waldorf-Astoria Hotel in New York City.
